Health promotion and disease prevention as a complement to community health indicators: Working group 1

International Journal of Technology Assessment in Health Care

Volumn 18, Issue 2, 2002, Pages 238-272

  Banta, H David ^a,b   Hatziandreu, Evridiki ^c   Dauben, Hans Peter ^d   Førde, Olav Helge ^e   Loud, Marlène Laeubli ^f   Isacsson, Sven Olof ^g   Paccaud, Fred ^h   Sanchez, Emilia ⁱ   Steiger, Therese Stutz ^f  

^a TNO   (Netherlands)

^b Swedish Council on Technology Assessment in Health Care   (Sweden)

^c Diagnostic Centre of Occupational Medicine   (Greece)

^d German Agency for Health Technology Assessment (DAHTA DIMDI)   (Germany)

^e UNIVERSITY OF TROMSØ   (Norway)

^f FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF LAUSANNE   (Switzerland)

ⁱ Catalan Agency for Health Technology Assessment and Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CONFERENCE PAPER; EUROPE; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; MEDICAL ETHICS; PROPHYLAXIS; PUBLIC HEALTH; RISK BENEFIT ANALYSIS;

EID: 0036099340     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0266462302000259     Document Type: Conference Paper

References (54)

1. Assessing the cost-effectiveness of prevention
2. Health policy, health technology assessment, and screening in Europe
3. Randomized trial of a brief HIV risk reduction counseling intervention for women
4. Mortality from causes amenable and non-amenable to medical care: The experience of eastern Europe
5. Some international comparisons of mortality amenable to medical intervention
6. Genetics, ethics and audit
7. Priorities among recommended clinical preventive services
8. Ethical and psychological aspects of screening
9. Changes in estimated coronary risk in the 1980s: Data from 38 populations in the WHO MONICA Project
10. Users' guides to the medical literature, XII: How to use an article on economic analysis of clinical practice
11. Primum non nocere and the quality of evidence: Rethinking the ethics of screening
12. Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analysis: A re-evaluation
13. Social support and cancer screening in African American, Hispanic and Native American women
14. Ethical issues in technology assessment: Conceptual categories and procedural considerations
15. Estimating the "avoidable" burden of disease by disability adjusted life years (DALYs)
16. Methods for priority setting among clinical preventive services
17. "Avoidable" mortality and health services: A review of aggregate data studies
18. The European health potential: What can we learn from each other?
19. Systematic review of the cost-effectiveness of public health interventions for HIV prevention in industrialized countries
20. Avoidable mortality in Europe, 1955-1994: A plea for prevention
21. Familial breast cancer: Some social, economic and ethical issues
22. Variations in "avoidable" mortality: A reflection of variations in incidence?
23. A framework for the evaluation of technology: The technology assessment iterative loop
24. The East-West life expectancy gap: Differences in mortality from conditions amenable to medical intervention
25. Trends in "avoidable" mortality in Sweden, 1974-1985
26. Socioeconomic differences in "avoidable" mortality in Sweden, 1986-1990
27. The European community "avoidable death indicators" in Sweden, 1974-1985